Trial Profile
An open-label study of the pharmacokinetics of Fuzeon in patients with HIV-1 infection and renal impairment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2010
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Roche
- 18 Nov 2010 Additional centres identified as reported by Roche website.
- 26 Feb 2010 New trial record